Cc1cc(C)cc(-c2nnc(SCC(=O)c3c(N)n(C4CC4)c(=O)[nH]c3=O)o2)c1
Orally active drug usually follows the rule of three, in which the molecular weight of a fragment is <300, the c Log P is ≤3, the number of hydrogen bond donors is ≤3 and the number of hydrogen bond acceptors is ≤3. The molecule meets rule of three or not?